| 000 | 01130 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512045149.0 | ||
| 264 | 0 | _c19871230 | |
| 008 | 198712s 0 0 eng d | ||
| 022 | _a0950-2688 | ||
| 024 | 7 |
_a10.1017/s0950268800067984 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaxter, D N | |
| 245 | 0 | 0 |
_aHow are the sub-unit pertussis vaccines to be evaluated? _h[electronic resource] |
| 260 |
_bEpidemiology and infection _cOct 1987 |
||
| 300 |
_a477-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMathematics |
| 650 | 0 | 4 |
_aPertussis Vaccine _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aWhooping Cough _xprevention & control |
| 700 | 1 | _aGibbs, A C | |
| 773 | 0 |
_tEpidemiology and infection _gvol. 99 _gno. 2 _gp. 477-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/s0950268800067984 _zAvailable from publisher's website |
| 999 |
_c3321465 _d3321465 |
||